SENTIS™ Hereditary Cancer

The Power Of Knowing

SENTIS™ Hereditary Cancer Testing uses target region capture combined with high-throughput sequencing technology to detect germline genes and assess the risk of 25 types of cancer, providing families with a comprehensive genetic cancer risk assessment.

Female Hereditary Cancer Panel
85 Genes 24 Cancer Types

Sample Requirements
Saliva

Male Hereditary Cancer Panel
90 Genes 23 Cancer Types

TAT
13 calendar days

Why choose us?

Comprehensive

Robust

Affordable

For more information on BGI’s Cancer+ Discovery Test :

Please refer https://www.bgi.com/global/molecular-genetics/sentis-oncology/bgi-sentis-cancer-discovery-panel/ or

For any medical enquiry,

Email us at info@sayretherapeutics.com